Neuralink builds implantable brain-computer interfaces, including the N1 implant, that convert neural signals into digital actions so people with quadriplegia can control computers and mobile devices by thought.
Neuralink develops implantable brain-computer interfaces that translate neural signals into digital actions, allowing direct control of computers and mobile devices by thought. Founded by Elon Musk and a team of scientists and engineers, the company works across neuroscience, microscale electronics and biomedical engineering, with a stated mission of restoring autonomy to individuals with unmet medical needs.
Its principal product is the N1 implant, a fully implantable and cosmetically invisible device designed to let people with quadriplegia operate computers and mobile devices through thought alone. Neuralink has received FDA approval for human clinical trials, and patients are already using the device to control computers.
The company operates in the healthcare, medical devices, neurology and assistive technology sectors. Technical work spans brain-computer interfaces, neurotechnology, neuroscience, microscale electronics, biomedical engineering, implantable medical devices and neural signal decoding. Further information is available at https://neuralink.com/.
